5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer

PVI 5FU gives increased response rates and reduced toxicity when compared to bolus 5FU (J Clin Oncol 1989, 425–432). PVI 5FU administration was reported to give highly variable (>1000-fold) plasma 5FU concentrations at steady state (FU Css) which correlated with toxicity (Ann Oncol 1996, 47–53);...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jodrell, D I, Stewart, M, Aird, R, Knowles, G, Bowman, A, Wall, L, Cummings, J, McLean, C
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2001
Soggetti:
Regular Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363784/
https://ncbi.nlm.nih.gov/pubmed/11237378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1664
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi